booksshare.net -> -> -> . -> " " -> 184

- .

. .: , 2007. 608 c.
ISBN 5-98657-009-
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 178 179 180 181 182 183 < 184 > 185 186 187 188 189 190 .. 345 >>

(2-Tetrahydro-
furfurylchlorid)
COOC2H5
H2C
'ооСгНб
Malonsaure-
diethylester
COOC2H5
/uy.CH2-CH
' C00CZH5
(2-Tetrahydrofurfuryl)-
matonsaurediethylester
1 NaQCjHs I |v |
2. K0H
3. HCl
1. 1-Chlormethyl-naphthalin
-CH2--CH-COOH
<^y-z H2
3-(l-Naphthyl)-2-{2-
tetrahydrofurfuryl)-propan-
Cl-CH2-CH2-N
2-Diethylaminoethyl-
chlorid
^Hs
CH2-CH-C0-0-CH2“CH2-Nn
■04 Jh2 CzHs
Or
Naftidrofuryl
616 N Naftidrofuryl - Nalbuphin - Nalidixinsaure
DOT 5,19(1969).
DAS 1543 741 (Lipha; Anm. 24.3.1964; F-Prior. 28.3.1963).
FP 1 363 948 (Lipha; Anm. 28.3.1963).
FP-M 3 843 (Lipha; Anm. 17.3.1964).
USP 3 334096 (Lipha; ert. 1.8.1967; F-Prior. 28.3.1963).
Galenische Formulierung fiir Retard-Form:
DOS 2 800 654 (Lipha; Anm. 7.1.1978; F-Prior. 13.1.1977).
D: Dusodril® (Lipha) GB: Praxilene® (Lipha)
F: Praxitene® (Oberval) I: Praxilene® (Formenti)
Nalbuphin
20594-83-6
23277-43-2 Hydrochlorid
Morphinantagonist;
Analgeticum
17-(cyclobutylmethyl)-4,5a-epoxymorphinan-3,6a,14-triol
Oc
HO °'
14-Hydroxydihydro-
normorphinon
(vgl. NaJoxon-Synthese. S. 618)
Cydobutan-
carbonsaurechlorid
1. NaBHt /С2Н5ОН
2. ф-СН2-Вг/0
1. Natnumborhydrid
2. Cyclobutylmelhyl-bromid
Natbuphin
DOF2,613 (1977); 3, 703 (1978); 4,690 (1979).
DOT 16,51 (1980).
GB-P 1119 270 (Endo; Laufzeit ab 16.12.1966; USA-Prior. 19.1.1966).
USP 3 332 950 (Endo; ert. 25.7.1967; Prior. 6.12.1966,15.5.1963,23.3.1963).
USA: Nubain® (Endo)
Nalidixinsaure
389-08-2
Chemotherapeuticum [gegen Harnwegs-infektionen]
l-ethyl-l,4-dihydro-7-methyl-4-oxo-l,8-naphthyridine-3-carboxylic acid
Nalidixinsaure - Nalorphin N 617
H3Cv.bL.NH2
XX
2-Amino-6-methyl-
pyridin
HsC20.
^CH
II
С
н5с2оос COOC2H5
Ethoxymethylen - malon -saurediethyl ester
H3C^,N^N^
T И
H5C2OOC
COOC2H5
COOC2H5
НзС N^,N
COOH
<*-Hydroxy-7-methyl-
1,8-naphthyridin-
3-carbonsaure
C2HS НзС NVN
W-.
Nalidixinsaure
DOT 1, 16(1965). USP3 149 104 (Sterling Drug; ert. 15.9.1964; Prior. 3.1.1961). G. Y. Lesher et al., J. Med Pharm. Chem. 5,1063 (1962). Alternativ-Synthese: GB-P 1 338 023 (Koli Chem. Comp.; Anm. 19.4.1971; J-Prior. 20.2.1970).
D: Nogram® (Winthrop)
F: Negram® (Winthrop)
GB: Negram® (Winthrop)
I: Betaxina® (Amelix)
Chemiurin® (Cifa)
Dixiben® (Benvegna)
Dixilina® (Magis)
Dixinal® (Zanardi)
Dixurol® (Iti)
Enexina® (Sit)
Eucistin® (San Carlo)
Faril®(Saita)
Nalicidin® (Schoum)
Nalidixin® (Nuovo Cons. Sanit. Naz.) Naligen® (Sam)
Naligram® (Geymonat Sud) Nalissina® (Armour Medicamental) Nalix® (Sigurta)
Nalurin® (Von Boch)
Naxuril® (Esterfarm)
Neg-Gram® (Winthrop)
Negabatt® (Dessy)
Pielos® (Stip)
Specifin® (Bergamon Soc. It.) Uratgin® (Ceccarrelli)
Uretrene® (Mitim)
Un-Flor® (Agips)
Uriclar® (Crosara)
Urisco® (Ici)
Uristeril® (Ripari-Gero) Urolex® (Sirt Bbp.)
Uromina® (Ausonia)
Uronax® (Demor)
Uroneg® (Ibim)
Uropan® (Tiber)
Valuren® (Intersint)
J: Entolon® (Sawai)
Innoxalon® (Sanko) Kusnarin® (Kodama) Mirtolor® (Zensei)
Mytacin® (Fuji)
Nalidicron® (San-A)
Nalidixic Acid (Koseibussitsu) Narigix® (Taiyo)
Uicelate® (Toyo Jozo) Oxoranil® (Mohan)
Poleon® (Sumitomo) Restelon® (Maruishi) Urologin N® (Takata) Wintomyion® (Daiichi) Wintron® (Tobishi)
USA: Ne GRAM® (Winthrop)
Nalorphin 62-67-9 Morphinantagonist
57-29-4 Hydrochlorid 1041-90-3 Hydrobromid
/V-allylnormorphine
618 N Naiorphin - Naloxon
но' o' -oh
Morphin
IH}C—C0);0
Нзс-со-о
0-C0-CH3
Diamorphin
H3C-CO-O
O-CO-CH3
USP 2364833 (Merck -f Co.; ert. 1944; Prior. 1941). USP 2 891954 (Merck + Co.; ert. 1959; Prior. 1951).
D: Lethidrone® (Wellcome) I: Norfin® (Lusofarmaco)
F: Nalorphine (Clin-Comar-Byla) USA: Nalline® (Merck Sharp 4- Dohme)
GB: Lethidrone® (Burroughs Wellcome)
Naloxon 465-65-6 Narcoticaantagonist
357-08-4 Hydrochloric!
(-)-12-allyl-7,7a,8?9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bof]fiiraib 5(6//)-one
H3C0
1 (4|C-C0»j0
2. BrCN_
2. Bromcyar
Oxymorphon
(14-Hydroxy-dihydro-
morphinon)
H3C —C0N
H3C-CO-O
H2C=CH-CH;~Br / NaHCO?
U-Hydroxy-dihydro-
normorphinon
Naloxon - Naltrexon - Nandrolon N 619
DOT 8, 295 (1972).
USP 3 254088 (M. J. Lewenstein; ert. 31.5.1966; Anm. 14.3.1961).
DBP 1 183 508 (M. J. Lewenstein; Anm. 7.3.1962; USA-Prior. 14.3.1961). GB-P 929 287 (Sankyo; Anm. 9.3.1962; J-Prior. 14.3.1961).
D: Narcanti® (Winthrop) USA: Narcan® (Endo)
GB: Narcan® (Winthrop)
Naltrexon
16590-41-3
16676-29-2 Hydrochlorid
Narcoticaantagonist
( — )-17-(cydopropylmethyl)-4,5a-epoxy-3,14-dihydroxymorphinan-6-one
/DMF ; 70°C. I Woche СНг~Sr _
Cyclop ropyl-methylbromid
К - Hydroxy-dihydro -normorphinon (Oxymorphon) {vgl. Naloxon-Synthese, S. 618)
HO O' ’0 Oxymorphon
CH2-0H ,
I / p-Toluolsulforsaure CH;—OH _1
Ethylen-
glykol
HO
[>-COCl/NIC2H5]3
Cyclopropan-
carbonsaure-
chlond
1. LiAlH*
2. NHtCl 3‘ HCl
0-co-o o-"
DOF 2,45 (1977); 3,81 (1978).
DAS 1 795 707 (Endo; Anm. 19.12.1966; USA-Prior. 19.1.1966).
<< 1 .. 178 179 180 181 182 183 < 184 > 185 186 187 188 189 190 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed